Association of microRNA-21 (miR-21) with efficacy of cetuximab (cet) and bevacizumab (bev) in patients with metastatic colorectal cancer (mCRC) within the FIRE-3 study (AIO KRK-0306)

L Miller-Phillips; LF von Weikersthal; F Kaiser; SE Al-Batran; T Heintges; Daniel Neureiter; C Kahl; F Kullmann; M Moehler; W Scheithauer; C Vazart; K Fontaine; S Held; DP Modest; J Neumann; A Jung; T Kirchner; V Heinemann; S Stintzing

doi:10.1093/annonc/mdy269.122

Association of microRNA-21 (miR-21) with efficacy of cetuximab (cet) and bevacizumab (bev) in patients with metastatic colorectal cancer (mCRC) within the FIRE-3 study (AIO KRK-0306)

L Miller-Phillips, LF von Weikersthal, F Kaiser, SE Al-Batran, T Heintges, Daniel Neureiter, C Kahl, F Kullmann, M Moehler, W Scheithauer, C Vazart, K Fontaine, S Held, DP Modest, J Neumann, A Jung, T Kirchner, V Heinemann, S Stintzing

Institute of Pathology

Research output: Contribution to journal › Abstract (Journal) › peer-review

Original language	English
Pages (from-to)	39-39
Journal	ANNALS OF ONCOLOGY
Volume	29
DOIs	https://doi.org/10.1093/annonc/mdy269.122
Publication status	Published - 2018
Event	43rd ESMO Congress (ESMO) - Munich, GERMANY Duration: 19 Oct 2018 → 23 Oct 2018

Access to Document

10.1093/annonc/mdy269.122

Cite this

Miller-Phillips, L., von Weikersthal, LF., Kaiser, F., Al-Batran, SE., Heintges, T., Neureiter, D., Kahl, C., Kullmann, F., Moehler, M., Scheithauer, W., Vazart, C., Fontaine, K., Held, S., Modest, DP., Neumann, J., Jung, A., Kirchner, T., Heinemann, V., & Stintzing, S. (2018). Association of microRNA-21 (miR-21) with efficacy of cetuximab (cet) and bevacizumab (bev) in patients with metastatic colorectal cancer (mCRC) within the FIRE-3 study (AIO KRK-0306). ANNALS OF ONCOLOGY , 29, 39-39. https://doi.org/10.1093/annonc/mdy269.122

Miller-Phillips, L ; von Weikersthal, LF ; Kaiser, F et al. / Association of microRNA-21 (miR-21) with efficacy of cetuximab (cet) and bevacizumab (bev) in patients with metastatic colorectal cancer (mCRC) within the FIRE-3 study (AIO KRK-0306). In: ANNALS OF ONCOLOGY 2018 ; Vol. 29. pp. 39-39.

@article{bf6b286813fd4110913e3f7d6272bbfc,

title = "Association of microRNA-21 (miR-21) with efficacy of cetuximab (cet) and bevacizumab (bev) in patients with metastatic colorectal cancer (mCRC) within the FIRE-3 study (AIO KRK-0306)",

author = "L Miller-Phillips and {von Weikersthal}, LF and F Kaiser and SE Al-Batran and T Heintges and Daniel Neureiter and C Kahl and F Kullmann and M Moehler and W Scheithauer and C Vazart and K Fontaine and S Held and DP Modest and J Neumann and A Jung and T Kirchner and V Heinemann and S Stintzing",

year = "2018",

doi = "10.1093/annonc/mdy269.122",

language = "English",

volume = "29",

pages = "39--39",

journal = "ANNALS OF ONCOLOGY ",

issn = "0923-7534",

publisher = "Elsevier ",

note = "43rd ESMO Congress (ESMO) ; Conference date: 19-10-2018 Through 23-10-2018",

}

Miller-Phillips, L, von Weikersthal, LF, Kaiser, F, Al-Batran, SE, Heintges, T, Neureiter, D, Kahl, C, Kullmann, F, Moehler, M, Scheithauer, W, Vazart, C, Fontaine, K, Held, S, Modest, DP, Neumann, J, Jung, A, Kirchner, T, Heinemann, V & Stintzing, S 2018, 'Association of microRNA-21 (miR-21) with efficacy of cetuximab (cet) and bevacizumab (bev) in patients with metastatic colorectal cancer (mCRC) within the FIRE-3 study (AIO KRK-0306)', ANNALS OF ONCOLOGY , vol. 29, pp. 39-39. https://doi.org/10.1093/annonc/mdy269.122

Association of microRNA-21 (miR-21) with efficacy of cetuximab (cet) and bevacizumab (bev) in patients with metastatic colorectal cancer (mCRC) within the FIRE-3 study (AIO KRK-0306). / Miller-Phillips, L; von Weikersthal, LF; Kaiser, F et al.
In: ANNALS OF ONCOLOGY , Vol. 29, 2018, p. 39-39.

Research output: Contribution to journal › Abstract (Journal) › peer-review

TY - JOUR

T1 - Association of microRNA-21 (miR-21) with efficacy of cetuximab (cet) and bevacizumab (bev) in patients with metastatic colorectal cancer (mCRC) within the FIRE-3 study (AIO KRK-0306)

AU - Miller-Phillips, L

AU - von Weikersthal, LF

AU - Kaiser, F

AU - Al-Batran, SE

AU - Heintges, T

AU - Neureiter, Daniel

AU - Kahl, C

AU - Kullmann, F

AU - Moehler, M

AU - Scheithauer, W

AU - Vazart, C

AU - Fontaine, K

AU - Held, S

AU - Modest, DP

AU - Neumann, J

AU - Jung, A

AU - Kirchner, T

AU - Heinemann, V

AU - Stintzing, S

PY - 2018

Y1 - 2018

U2 - 10.1093/annonc/mdy269.122

DO - 10.1093/annonc/mdy269.122

M3 - Abstract (Journal)

C2 - 32136959

SN - 0923-7534

VL - 29

SP - 39

EP - 39

JO - ANNALS OF ONCOLOGY

JF - ANNALS OF ONCOLOGY

T2 - 43rd ESMO Congress (ESMO)

Y2 - 19 October 2018 through 23 October 2018

ER -

Miller-Phillips L, von Weikersthal LF, Kaiser F, Al-Batran SE, Heintges T, Neureiter D et al. Association of microRNA-21 (miR-21) with efficacy of cetuximab (cet) and bevacizumab (bev) in patients with metastatic colorectal cancer (mCRC) within the FIRE-3 study (AIO KRK-0306). ANNALS OF ONCOLOGY . 2018;29:39-39. doi: 10.1093/annonc/mdy269.122